OSANG Healthcare Overview
- Year Founded
-
1996
- Status
-
Private
- Employees
-
333
- Latest Deal Type
-
M&A
- (Cancelled)
- Latest Deal Amount
-
$30.5M
- Investors
-
1
OSANG Healthcare General Information
Description
Developer of diagnostic biosensors for blood glucose measurement intended to create value for customers through innovation and differentiating technology. The company's product offering includes a blood glucose monitoring system, HbA1c analyzer, cholesterol measuring system, immune diagnostic device, and molecular diagnostic devices, enabling customers to easily measure diseases.
Contact Information
Website
www.osanghc.comCorporate Office
- 132, Anyangcheondong-ro
- Dongan-gu
- Anyang, Gyeonggi-do 431-080
- South Korea
Corporate Office
- 132, Anyangcheondong-ro
- Dongan-gu
- Anyang, Gyeonggi-do 431-080
- South Korea
OSANG Healthcare Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Merger/Acquisition | 03-Apr-2015 | $30.5M | Cancelled | Profitable | ||
2. IPO | 05-Jun-2007 | Completed | Generating Revenue | |||
1. Early Stage VC | Completed | Startup |
OSANG Healthcare Patents
OSANG Healthcare Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4202411-A1 | Measurement device with light quantity correction function and light quantity correction method thereof | Inactive | 27-Dec-2021 | ||
US-20230147691-A1 | Method of manufacturing coronavirus diagnostic kit, virus diagnostic kit manufactured thereby and method of diagnosing coronavirus using the same | Active | 22-Apr-2020 | ||
US-11976338-B2 | Method of manufacturing coronavirus diagnostic kit, virus diagnostic kit manufactured thereby and method of diagnosing coronavirus using the same | Active | 22-Apr-2020 | ||
EP-4109077-A1 | Chromatographic testing device configured to select imaging scheme according to type of fluorescent dye, and method for controlling same | Pending | 21-Feb-2020 | ||
US-20230055598-A1 | Chromatographic testing device configured to select imaging scheme according to type of fluorescent dye, and method for controlling same | Pending | 21-Feb-2020 | G01N21/6428 |
OSANG Healthcare Signals
OSANG Healthcare Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
EastBridge Partners | PE/Buyout | Majority |
OSANG Healthcare Investments (6)
OSANG Healthcare’s most recent deal was a Later Stage VC with Allez Health for . The deal was made on 22-May-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Allez Health | 22-May-2024 | Later Stage VC | Monitoring Equipment | ||
Kryptos Biotechnologies | 08-Apr-2024 | Later Stage VC | Diagnostic Equipment | ||
Alle Health | 06-Apr-2024 | Later Stage VC | Diagnostic Equipment | ||
Wisemedi | 11-Mar-2024 | Corporate | Pharmaceuticals | ||
Wisemedi | 01-May-2023 | Corporate | Pharmaceuticals |
OSANG Healthcare FAQs
-
When was OSANG Healthcare founded?
OSANG Healthcare was founded in 1996.
-
Where is OSANG Healthcare headquartered?
OSANG Healthcare is headquartered in Anyang, South Korea.
-
What is the size of OSANG Healthcare?
OSANG Healthcare has 333 total employees.
-
What industry is OSANG Healthcare in?
OSANG Healthcare’s primary industry is Diagnostic Equipment.
-
Is OSANG Healthcare a private or public company?
OSANG Healthcare is a Private company.
-
What is the current valuation of OSANG Healthcare?
The current valuation of OSANG Healthcare is
. -
What is OSANG Healthcare’s current revenue?
The current revenue for OSANG Healthcare is
. -
Who are OSANG Healthcare’s investors?
EastBridge Partners has invested in OSANG Healthcare.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »